Autologous Transplantation in Follicular Lymphoma with Early Therapy Failure: A National LymphoCare Study and Center for International Blood and Marrow Transplant Research AnalysisCarla Casulo, Mehdi Hamadani, Jonathan W. Friedberg et al.|Transplantation and Cellular Therapy|2017Cited by 141
Identification and Characterization of Tumor-Initiating Cells in Multiple MyelomaMinjie Gao, Fenghuang Zhan, Hua Bai et al.|JNCI Journal of the National Cancer Institute|2019Cited by 47
C-Reactive Protein Monitoring Predicts Neutropenic Fever Following Autologous Hematopoietic Stem Cell Transplantation for Multiple MyelomaVidya Kollu, Guido Tricot, Sarah L. Mott et al.|Cureus|2018Cited by 8
Bloodless tandem autologous transplant in Jehovah’s Witness patientsRafiullah Khan, Guido Tricot, Sarah L. Mott et al.|Bone Marrow Transplantation|2018Cited by 7
A Single Autologous Stem Cell Transplant (ASCT) Followed By Two Years of Post-Transplant Therapy in Recently Diagnosed Elderly Multiple Myeloma (MM) Patients. Safety and Response Results from the Prospective Phase II Trial (NCT01849783)Kalyan Nadiminti, Yogesh Jethava, Christopher Strouse et al.|Blood|2018Cited by 5